Literature DB >> 21282101

ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells.

Michael Boergesen1, Lars la Cour Poulsen, Søren Fisker Schmidt, Francesca Frigerio, Pierre Maechler, Susanne Mandrup.   

Abstract

Chronic exposure to elevated levels of glucose and fatty acids leads to dysfunction of pancreatic β-cells by mechanisms that are only partly understood. The transcription factor peroxisome proliferator-activated receptor α (PPARα) is an important regulator of genes involved in fatty acid metabolism and has been shown to protect against lipid-induced β-cell dysfunction. We and others have previously shown that expression of the PPARα gene in β-cells is rapidly repressed by glucose. Here we show that the PPARα gene is transcribed from five alternative transcription start sites, resulting in three alternative first exons that are spliced to exon 2. Expression of all PPARα transcripts is repressed by glucose both in insulinoma cells and in isolated pancreatic islets. The observation that the dynamics of glucose repression of PPARα transcription are very similar to those of glucose activation of target genes by the carbohydrate response element-binding protein (ChREBP) prompted us to investigate the potential role of ChREBP in the regulation of PPARα expression. We show that a constitutively active ChREBP lacking the N-terminal domain efficiently represses PPARα expression in insulinoma cells and in rodent and human islets. In addition, we demonstrate that siRNA-mediated knockdown of ChREBP abrogates glucose repression of PPARα expression as well as induction of well established ChREBP target genes in insulinoma cells. In conclusion, this work shows that ChREBP is a critical and direct mediator of glucose repression of PPARα gene expression in pancreatic β-cells, suggesting that ChREBP may be important for glucose suppression of the fatty acid oxidation capacity of β-cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282101      PMCID: PMC3075668          DOI: 10.1074/jbc.M110.215467

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Metabolic fate of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells.

Authors:  F Schuit; A De Vos; S Farfari; K Moens; D Pipeleers; T Brun; M Prentki
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).

Authors:  T Aoyama; J M Peters; N Iritani; T Nakajima; K Furihata; T Hashimoto; F J Gonzalez
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

3.  Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels.

Authors:  S Gremlich; C Bonny; G Waeber; B Thorens
Journal:  J Biol Chem       Date:  1997-11-28       Impact factor: 5.157

4.  Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.

Authors:  S Kersten; J Seydoux; J M Peters; F J Gonzalez; B Desvergne; W Wahli
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

5.  A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.

Authors:  F Djouadi; C J Weinheimer; J E Saffitz; C Pitchford; J Bastin; F J Gonzalez; D P Kelly
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

6.  The pentose cycle and insulin release in isolated mouse pancreatic islets during starvation.

Authors:  C J Hedeskov; K Capito
Journal:  Biochem J       Date:  1975-12       Impact factor: 3.857

7.  Glucose-stimulated synthesis of fructose 2,6-bisphosphate in rat liver. Dephosphorylation of fructose 6-phosphate, 2-kinase:fructose 2,6-bisphosphatase and activation by a sugar phosphate.

Authors:  M Nishimura; S Fedorov; K Uyeda
Journal:  J Biol Chem       Date:  1994-10-21       Impact factor: 5.157

8.  Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells.

Authors:  Y T Zhou; M Shimabukuro; M Y Wang; Y Lee; M Higa; J L Milburn; C B Newgard; R H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  The subcellular localization of the ChoRE-binding protein, encoded by the Williams-Beuren syndrome critical region gene 14, is regulated by 14-3-3.

Authors:  Giuseppe Merla; Cédric Howald; Stylianos E Antonarakis; Alexandre Reymond
Journal:  Hum Mol Genet       Date:  2004-05-26       Impact factor: 6.150

10.  Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three distinct mechanisms: lack of evidence for labile repressors.

Authors:  D R Edwards; L C Mahadevan
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more
  13 in total

1.  FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.

Authors:  Carly Kibbe; Junqin Chen; Guanlan Xu; Gu Jing; Anath Shalev
Journal:  J Biol Chem       Date:  2013-06-26       Impact factor: 5.157

Review 2.  Fructose and hepatic insulin resistance.

Authors:  Samir Softic; Kimber L Stanhope; Jeremie Boucher; Senad Divanovic; Miguel A Lanaspa; Richard J Johnson; C Ronald Kahn
Journal:  Crit Rev Clin Lab Sci       Date:  2020-01-14       Impact factor: 6.250

Review 3.  Carbon source metabolism and its regulation in cancer cells.

Authors:  Chengqian Yin; Shuo Qie; Nianli Sang
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2012       Impact factor: 1.807

4.  Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.

Authors:  Yan Lu; Xing Liu; Yang Jiao; Xuelian Xiong; E Wang; Xiaolin Wang; Zhijian Zhang; Huijie Zhang; Lingling Pan; Youfei Guan; Dongsheng Cai; Guang Ning; Xiaoying Li
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

Review 5.  Fructose metabolism and metabolic disease.

Authors:  Sarah A Hannou; Danielle E Haslam; Nicola M McKeown; Mark A Herman
Journal:  J Clin Invest       Date:  2018-02-01       Impact factor: 14.808

6.  FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance.

Authors:  Alli M Nuotio-Antar; Naravat Poungvarin; Ming Li; Michael Schupp; Mahmoud Mohammad; Sarah Gerard; Fang Zou; Lawrence Chan
Journal:  Endocrinology       Date:  2015-08-06       Impact factor: 4.736

Review 7.  Adaptive and maladaptive roles for ChREBP in the liver and pancreatic islets.

Authors:  Liora S Katz; Sharon Baumel-Alterzon; Donald K Scott; Mark A Herman
Journal:  J Biol Chem       Date:  2021-04-02       Impact factor: 5.157

8.  Acute TNF-induced repression of cell identity genes is mediated by NFκB-directed redistribution of cofactors from super-enhancers.

Authors:  Søren Fisker Schmidt; Bjørk Ditlev Larsen; Anne Loft; Ronni Nielsen; Jesper Grud Skat Madsen; Susanne Mandrup
Journal:  Genome Res       Date:  2015-06-25       Impact factor: 9.043

9.  iRNA-seq: computational method for genome-wide assessment of acute transcriptional regulation from total RNA-seq data.

Authors:  Jesper Grud Skat Madsen; Søren Fisker Schmidt; Bjørk Ditlev Larsen; Anne Loft; Ronni Nielsen; Susanne Mandrup
Journal:  Nucleic Acids Res       Date:  2015-01-06       Impact factor: 16.971

10.  Transient Decrease in Circulatory Testosterone and Homocysteine Precedes the Development of Metabolic Syndrome Features in Fructose-Fed Sprague Dawley Rats.

Authors:  Anil Sakamuri; Sujatha Pitla; Uday Kumar Putcha; Sugeedha Jayapal; Sailaja Pothana; Sai Santosh Vadakattu; Nagabhushan Reddy Konapalli; Siva Sankara Vara Prasad Sakamuri; Ahamed Ibrahim
Journal:  J Nutr Metab       Date:  2016-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.